M&A Deal Summary

DiaMedica Acquires Sanomune

On June 1, 2010, DiaMedica acquired medical products company Sanomune

Acquisition Highlights
  • This is DiaMedica’s 1st transaction in the Medical Products sector.
  • This is DiaMedica’s 1st transaction in Canada.
  • This is DiaMedica’s 1st transaction in Manitoba.

M&A Deal Summary

Date 2010-06-01
Target Sanomune
Sector Medical Products
Buyer(s) DiaMedica
Deal Type Add-on Acquisition

Target

Sanomune

Winnipeg, Manitoba, Canada
Sanomune Inc., is a privately held biopharmaceutical company focused on neurological disorders ("Sanomune").

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

DiaMedica

Minneapolis, Minnesota, United States

Category Company
Founded 2000
Sector Life Science
Employees2
DESCRIPTION

DiaMedica is a clinical stage biopharmaceutical company focused on the development of novel, first-in-class therapies for metabolic disorders, kidney dysfunction and orphan diseases. DiaMedica was founded in 2000 and is based in Minneapolis, Minnesota.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Manitoba M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2010 M&A 1 of 1